An incomplete and overly optimistic story about a treatment that hasn’t advanced beyond a test tube.
Excellent job on a story that received very little mainstream news media attention.
Better in some respects than the competing HealthDay coverage, but worse in others. Neither story got at the heart of why this study is important.
This story attempted to address some complicated nutrition science, but didn’t quite measure up. TIME‘s report was similar.
This was a superficial report that passed along the main findings of a study, but not much else.
After all of the research about lumpectomy & radiation versus mastectomy, what made this study new and significant? This story should have done a better job of explaining what made this a “more real-world study.”
A 275-word story that apparently came directly from a drug company news release. It leaves the reader with no new and meaningful information about the drug or disorder it targets.
A business story that is just as meaningful to patients and their family members as it is to investors.
In fewer than 500 words, this story managed to satisfactorily address 7 of our 10 criteria.